Recent News

Get to Know Dr. Matt Sampson

NephCure is proud to honor Dr. Matthew Sampson as our 2021 Boston Countdown to a Cure Medical Honoree, recognizing his outstanding contributions to nephrology and the NephCure community. Dr. Sampson is a Pediatric Nephrologist at Boston Children’s Hospital and holds the Warren E. Grupe Endowed Chair in Nephrology. He is also an Associate Professor of […]

Encouraging interim results from Travere’s PROTECT trial for IgAN patients

Interim results have been announced  from Travere Therapeutic’s PROTECT study, and although preliminary, the data look promising for IgA Nephropathy (IgAN) patients.  Travere’s ongoing Phase 3 trial is studying the drug sparsentan in IgAN patients.  On average, patients who received sparsentan experienced a nearly 50% reduction of proteinuria after 36 weeks. That’s roughly three times […]

Read More Recent News

Upcoming Events

+